Filter by
Filter by
Hematologic Toxicity Comparison of Intensity Modulated Proton Therapy and Intensity Modulated Radiation Therapy in Anal Cancer Patients.
This study compared hematologic toxicity in 41 anal cancer patients treated with IMPT (n=14) or IMRT (n=27). This study found all pelvic bone marrow dose...
Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.
This study from Japan included 100 patients with localized prostate cancer treated with moderately hypofractionated PT (70 GyRBE in 28 fractions) for evaluation...
Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer.
PARTIQoL is a multi-center phase 3 randomized trial comparing proton and photon for intermediate- or low-risk prostate cancer with a primary endpoint to compare...
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
Published in the Red Journal, this is a report from the PARTIQoL trial focusing on describing the trial design, patient baseline features, clinical details of...
Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.
This study compared PBS toxicity rates with those of passive scattering/uniform scanning (PS/US) in a prospective multicenter registry. For low-to-intermediate...